Investing News Network

Markets
TSX20532.18+148.43
TSXV714.66+12.92
DOW32637.19+516.91
S&P 5004057.84+79.11
NASD11740.65+305.91
ASX7155.20+26.40
Commodities
Gold1851.42-1.64
Silver22.01-0.01
Copper4.27+0.01
Palladium2021.50+13.50
Platinum953.00+4.00
Oil114.05-0.04
Heating Oil3.86+0.01
Natural Gas8.83-0.07
Currencies
BTCUSD29343.91-57.94
USDCAD1.2769-0.0006
USDEUR0.9312-0.0006
USDGBP0.7921-0.0005
USDAUD1.4065-0.0022
USDJPY127.15+0.05

Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43 rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16 th . Jennifer Taubert Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time) .

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .

Keep reading... Show less

Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43 rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos Verdes, CA on Thursday, June 16 th . Jennifer Taubert Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time) .

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .

Keep reading... Show less

Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company

The Company has also appointed Paul Ruh as CFO Designate

Mongon and Ruh to Assume New Leadership Roles Upon the Completion of the Planned Separation of the Consumer Health Business

Keep reading... Show less
×